Gut microbiota produce alcohol and contribute to NAFLD

Gut

Volumn 65, Issue 7, 2016, Pages 1232-

  Zhu, Lixin ^a,b   Baker, Robert D ^a,b   Zhu, Ruixin ^c   Baker, Susan S ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CATALASE; CYTOCHROME P450 2E1; MESSENGER RNA; VASOPRESSIN;

ALCOHOL BLOOD LEVEL; ALCOHOL METABOLISM; HUMAN; INTESTINE FLORA; MICROBIOME; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; MICROFLORA;

ETHANOL; GASTROINTESTINAL MICROBIOME; HUMANS; MICROBIOTA; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84962319422     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-311571     Document Type: Note

References (10)

1. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000;119:1340-7.
2. Zhu L, Baker RD, Baker SS. Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res 2015;77:245-51.
3. Volynets V, Küper MA, Strahl S, et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2012;57: 1932-41.
4. Michail S, Lin M, Frey MR, et al. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. FEMS Microbiol Ecol 2015;91:1-9.
5. Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013;57:601-9.
6. Engstler AJ, Aumiller T, Degen C, et al. Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. Gut Published Online First: 25 May 2015. doi:10.1136/gutjnl-2014-308379
7. Weltman MD, Farrell GC, Hall P, et al. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.
8. Chalasani N, Gorski JC, Asghar MS, et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003;37:544-50.
9. Baker SS, Baker RD, Liu W, et al. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS ONE 2010;5:e9570.
10. Zhu R, Baker SS, Moylan CA, et al. Systematic transcriptome analysis reveals elevated expression of alcohol metabolizing genes in NAFLD livers. J Pathol 2016;238:531-42.